GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Trillium Therapeutics Inc (NAS:TRIL) » Definitions » Book Value per Share

Trillium Therapeutics (Trillium Therapeutics) Book Value per Share : $2.17 (As of Sep. 2021)


View and export this data going back to 2009. Start your Free Trial

What is Trillium Therapeutics Book Value per Share?

Trillium Therapeutics's book value per share for the quarter that ended in Sep. 2021 was $2.17.

During the past 12 months, Trillium Therapeutics's average Book Value Per Share Growth Rate was 26.40% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 19.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Trillium Therapeutics was 104.00% per year. The lowest was -42.20% per year. And the median was -7.50% per year.

Trillium Therapeutics's current price is $18.44. Its book value per share for the quarter that ended in Sep. 2021 was $2.17. Hence, today's PB Ratio of Trillium Therapeutics is 8.51.

During the past 13 years, the highest P/B Ratio of Trillium Therapeutics was 18.96. The lowest was 2.48. And the median was 5.65.


Trillium Therapeutics Book Value per Share Historical Data

The historical data trend for Trillium Therapeutics's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Trillium Therapeutics Book Value per Share Chart

Trillium Therapeutics Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Book Value per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.47 1.52 -0.48 -0.87 2.56

Trillium Therapeutics Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.64 2.56 2.50 2.33 2.17

Competitive Comparison of Trillium Therapeutics's Book Value per Share

For the Biotechnology subindustry, Trillium Therapeutics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Trillium Therapeutics's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Trillium Therapeutics's PB Ratio distribution charts can be found below:

* The bar in red indicates where Trillium Therapeutics's PB Ratio falls into.



Trillium Therapeutics Book Value per Share Calculation

Trillium Therapeutics's Book Value Per Share for the fiscal year that ended in Dec. 2020 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(278.85-15.70)/102.93
=2.56

Trillium Therapeutics's Book Value Per Share for the quarter that ended in Sep. 2021 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(243.16-15.70)/105.00
=2.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


Trillium Therapeutics  (NAS:TRIL) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Trillium Therapeutics Book Value per Share Related Terms

Thank you for viewing the detailed overview of Trillium Therapeutics's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Trillium Therapeutics (Trillium Therapeutics) Business Description

Traded in Other Exchanges
N/A
Address
100 CambridgePark Drive, Suite 510, Cambridge, MA, USA, 02140
Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.